These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
375 related articles for article (PubMed ID: 21429430)
1. [Analysis of prophylactic chemotherapy outcome and clinical characteristics in patients of high-risk hydatidiform mole]. Geng S; Feng FZ; Xiang Y; Wan XR; Zhou Y Zhonghua Fu Chan Ke Za Zhi; 2011 Jan; 46(1):24-7. PubMed ID: 21429430 [TBL] [Abstract][Full Text] [Related]
2. [Clinical analysis of patients with relapsed and chemo-resistant gestational trophoblastic neoplasia]. Zhou Y; Feng FZ; Xiang Y; Wan XR Zhonghua Fu Chan Ke Za Zhi; 2010 Nov; 45(11):804-7. PubMed ID: 21211275 [TBL] [Abstract][Full Text] [Related]
3. [Therapeutic evaluation of cisplatin, etoposide, and bleomycin chemotherapy regimen in high-risk gestational trophoblastic neoplasia]. Song SQ; Zhang GN Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):571-6. PubMed ID: 23141175 [TBL] [Abstract][Full Text] [Related]
4. Prediction of persistent gestational trophobalstic neoplasia: the role of hCG level and ratio in 2 weeks after evacuation of complete mole. Kang WD; Choi HS; Kim SM Gynecol Oncol; 2012 Feb; 124(2):250-3. PubMed ID: 22094931 [TBL] [Abstract][Full Text] [Related]
5. Recurrent gestational trophoblastic disease after hCG normalization following hydatidiform mole in The Netherlands. Kerkmeijer LG; Wielsma S; Massuger LF; Sweep FC; Thomas CM Gynecol Oncol; 2007 Jul; 106(1):142-6. PubMed ID: 17462723 [TBL] [Abstract][Full Text] [Related]
6. Gestational trophoblastic neoplasia after achieving a nondetectable serum human chorionic gonadotrophin level. Gueye M; Kane-Gueye SM; Ndiaye-Gueye MD; Mbaye M; Diouf AA; Niang MM; Diallo M; Moreau JC BJOG; 2014 Oct; 121(11):1415-9. PubMed ID: 24674295 [TBL] [Abstract][Full Text] [Related]
7. Measurement of CA-125 in trophoblastic disease. Kohorn EI Gynecol Oncol; 2000 Jul; 78(1):39-42. PubMed ID: 10873407 [TBL] [Abstract][Full Text] [Related]
8. Is chemotherapy necessary for patients with molar pregnancy and human chorionic gonadotropin serum levels raised but falling at 6months after uterine evacuation? Braga A; Torres B; Burlá M; Maestá I; Sun SY; Lin L; Madi JM; Uberti E; Viggiano M; Elias KM; Berkowitz RS Gynecol Oncol; 2016 Dec; 143(3):558-564. PubMed ID: 27640962 [TBL] [Abstract][Full Text] [Related]
9. Management of gestational trophoblastic neoplasia with 5-fluorouracil and actinomycin D in northern China. Zhao Y; Zhang W; Duan W J Reprod Med; 2009 Feb; 54(2):88-94. PubMed ID: 19301571 [TBL] [Abstract][Full Text] [Related]
10. [Efficacy of surgical management combined with chemotherapy in the treatment of drug-resistant gestational trophoblastic neoplasm]. Feng FZ; Xiang Y; Cao Y; Li L; Wan XR; Yang XY Zhonghua Fu Chan Ke Za Zhi; 2008 Oct; 43(10):728-31. PubMed ID: 19087536 [TBL] [Abstract][Full Text] [Related]
11. Low-risk gestational trophoblastic neoplasia and methotrexate resistance: predictors of response to treatment with actinomycin D and need for combination chemotherapy. Growdon WB; Wolfberg AJ; Goldstein DP; Feltmate CM; Chinchilla ME; Lieberman ES; Berkowitz RS J Reprod Med; 2010; 55(7-8):279-84. PubMed ID: 20795339 [TBL] [Abstract][Full Text] [Related]
12. Management of drug resistant gestational trophoblastic neoplasia. Patel SM; Desai A J Reprod Med; 2010; 55(7-8):296-300. PubMed ID: 20795341 [TBL] [Abstract][Full Text] [Related]
13. Human chorionic gonadotrophin regression rate as a predictive factor of postmolar gestational trophoblastic neoplasm in high-risk hydatidiform mole: a case-control study. Kim BW; Cho H; Kim H; Nam EJ; Kim SW; Kim S; Kim YT; Kim JH Eur J Obstet Gynecol Reprod Biol; 2012 Jan; 160(1):100-5. PubMed ID: 22055909 [TBL] [Abstract][Full Text] [Related]
14. Persistent trophoblast disease following partial molar pregnancy. Wielsma S; Kerkmeijer L; Bekkers R; Pyman J; Tan J; Quinn M Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):119-23. PubMed ID: 16638033 [TBL] [Abstract][Full Text] [Related]
15. Serum human chorionic gonadotropin regression pattern in persistent trophoblastic disease during chemotherapy. Lertkhachonsuk R; Limpongsanurak S J Med Assoc Thai; 2001 Jun; 84 Suppl 1():S352-9. PubMed ID: 11529357 [TBL] [Abstract][Full Text] [Related]
16. Comparison of human chorionic gonadotropin +beta and invasive trophoblast antigen disappearance rates in serum after evacuation of molar pregnancy. Van Trommel NE; Sweep FC; Ross HA; Massuger LF; Thomas CM Int J Mol Med; 2006 Oct; 18(4):705-11. PubMed ID: 16964426 [TBL] [Abstract][Full Text] [Related]
17. Relapse rates after two versus three consolidation courses of methotrexate in the treatment of low-risk gestational trophoblastic neoplasia. Lybol C; Sweep FC; Harvey R; Mitchell H; Short D; Thomas CM; Ottevanger PB; Savage PM; Massuger LF; Seckl MJ Gynecol Oncol; 2012 Jun; 125(3):576-9. PubMed ID: 22410329 [TBL] [Abstract][Full Text] [Related]
18. Prevention of postmolar gestational trophoblastic neoplasia using prophylactic single bolus dose of actinomycin D in high-risk hydatidiform mole: a simple, effective, secure and low-cost approach without adverse effects on compliance to general follow-up or subsequent treatment. Uberti EM; Fajardo Mdo C; da Cunha AG; Rosa MW; Ayub AC; Graudenz Mda S; Schmid H Gynecol Oncol; 2009 Aug; 114(2):299-305. PubMed ID: 19427681 [TBL] [Abstract][Full Text] [Related]